BY | November 17, 2012

Bhubaneswar, (IANS) Health officials Saturday confirmed 22 new cases of dengue in Odisha, taking the total number of people in the state infected with the disease to 2,051 this year.

The highest number of new cases, seven, was reported from Jajpur district, M.M. Pradhan, joint director of the state health department, told IANS.

The death toll due to the mosquito-borne disease has, however, remained at six with no person dying of dengue in Odisha since the last week of October, Pradhan said.

RELATED

Anxiety following false-positive mammogram results end early   For every person this is like bad dream. A positive mammogram result may be a bad news for anyone among us. And the same impact is made on the person if a false positive result is given to him in case of...

Roche’s breast cancer drug Kadcyla price far too high There is no denying the fact that Roche’s Kadcyla is a very effective breast cancer drug. Its positive impacts on the patients suffering from breast cancer have been praised by doctors and experts across the...

Internet connects retirees with others, saves from depression   Loneliness is the biggest and the most depressing aspect of elderly people’s life. As they age, the number of people they interact with starts going down and in many cases most people are not left with...

aanty-devi

Malignant melanoma rises five times since 70s     More and more people are being diagnosed of malignant melanoma these days. In 1970, their numbers were five times less than what it is today, according to experts. But the silver lining in the dark cloud is...

cancer-cell

Infertility treatment in focus   Is your state “fertility friendly”? This and others questions are being debated on the National Infertility Week. Its importance is being felt at a time when the National Infertility Association has released its annual Fertility...

Sarepta’s Duchenne muscular dystrophy (DMD) drug Eteplirsen gets lifeline by FDA   Sarepta Therapeutics Inc's shares jumped to a record high as the US Food and Drug Administration (FDA) showed its preparedness to approve its experimental muscle disorder...